ESC Premium Access

A randomized trial comparing a novel sirolimus-eluting bioresorbable scaffold with everolimus-eluting metallic stents in patients with coronary artery disease

Presentation

About the speaker

Professor Yaling Han

General Hospital Of Shenyang Military Region, Shenyang (China)
1 presentation
0 follower

9 more presentations in this session

Early and Late target lesion failure and thrombosis after implantation of coronary bioresorbable scaffolds: analysis of predictors and mechanisms.

Speaker: Doctor T. Gori (Mainz, DE)

Thumbnail

Major coronary evaginations following implantation of bioresorbable vascular scaffolds: clinical and OCT characteristics

Speaker: Doctor F. Blachutzik (Giessen, DE)

Thumbnail

One-year clinical outcomes following bioresorbable vascular scaffold implantation in patients presenting with acute coronary syndromes versus stable coronary artery disease: results from RAI registry

Speaker: Doctor E. Moscarella (Caserta, IT)

Thumbnail

Bioresorbable vascular scaffolds versus metallic stents in patients with STsegment

Speaker: Doctor T. Kofler (Lucerne, CH)

Thumbnail

Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

Speaker: Doctor P. Chandra (Gurgaon, IN)

Thumbnail

Access the full session

Bioresorbable vascular scaffolds: still the future or already the past?

Speakers: Professor Y. Han, Doctor T. Gori, Doctor F. Blachutzik, Doctor E. Moscarella, Doctor T. Kofler...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk